<code id='BBB238AA3F'></code><style id='BBB238AA3F'></style>
    • <acronym id='BBB238AA3F'></acronym>
      <center id='BBB238AA3F'><center id='BBB238AA3F'><tfoot id='BBB238AA3F'></tfoot></center><abbr id='BBB238AA3F'><dir id='BBB238AA3F'><tfoot id='BBB238AA3F'></tfoot><noframes id='BBB238AA3F'>

    • <optgroup id='BBB238AA3F'><strike id='BBB238AA3F'><sup id='BBB238AA3F'></sup></strike><code id='BBB238AA3F'></code></optgroup>
        1. <b id='BBB238AA3F'><label id='BBB238AA3F'><select id='BBB238AA3F'><dt id='BBB238AA3F'><span id='BBB238AA3F'></span></dt></select></label></b><u id='BBB238AA3F'></u>
          <i id='BBB238AA3F'><strike id='BBB238AA3F'><tt id='BBB238AA3F'><pre id='BBB238AA3F'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:8613
          gantenerumab Alzheimer's disease Roche
          Sebastien Bozon/AFP via Getty Images

          LONDON — The booming obesity market is attracting another player, as pharma giant Roche said Monday it was acquiring Carmot Therapeutics and the company’s line of weight loss drug candidates for $2.7 billion upfront. 

          The deal for Carmot, which is based in Berkeley, Calif., includes additional milestone payments of up to $400 million. Carmot is privately held, though it had filed paperwork last month for an initial public offering. 

          advertisement

          As part of the deal, Roche is gaining three experimental obesity medicines from Carmot, which are in Phase 1 or Phase 2 testing, as well as preclinical programs. While two are injectable treatments, one is being developed as an oral drug. They all target GLP-1 hormone receptors, while two are also designed to work via receptors for another hormone called GIP. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          Testing GLP
          Testing GLP

          NoraVolkow(right)saidinaconversationwithSTAT'sElaineChen:“Thisisastructuralproblemthatwehave:Thatwe’

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          Twill hunts for pharma partner to market its depression app

          AlexHogan/STATInanothersignofthebusinessheadwindsfacingprescriptionmentalhealthapps,developerTwillwi